Estate Criticized Johns Hopkins Memorial Plans
The executor for the Henrietta Lacks estate has raised concerns about the planning of an upcoming lecture.
Updated on Oct. 10, 2026 in Cancer
Live Poll
Should the families of deceased persons have veto power over events held in their name?
Ron Lacks, executor of the Henrietta Lacks estate, has publicly expressed grievances regarding the 16th annual Henrietta Lacks Memorial Lecture scheduled by Johns Hopkins. The dispute follows a series of recent settlements the estate reached with various pharmaceutical and biotechnology companies.
Why it matters
Disagreements over the memorial event highlight ongoing tensions between the institution where Henrietta Lacks was treated and her surviving family. These conflicts continue to shape the legacy of her contributions to medical research seventy-five years after her passing.
Johns Hopkins scheduled the 16th annual Henrietta Lacks Memorial Lecture for October 10, 2026. This follows the 2023 settlement with Thermo Fisher Scientific and subsequent 2026 settlements with Novartis and Viatris.
The players
Ron Lacks
The executor of the estate of Henrietta Lacks who has publicly criticized planning for the upcoming memorial lecture.
Johns Hopkins
A medical and research institution that treated Henrietta Lacks and hosts an annual lecture series in her honor.
Henrietta Lacks
A woman whose cells were collected in 1951 and became a foundational tool for global medical and pharmaceutical research.
The details
The controversy stems from the management of the memorial lecture, with Ron Lacks specifically citing the denial of his request for a table to display his book. While Johns Hopkins maintains it never sold or profited from the HeLa cells collected from Henrietta Lacks in 1951, the estate has pursued legal action against several firms over the commercialization of these cell lines. The institution remains the site of both the original cell collection and the planned memorial event.
Timeline
Henrietta Lacks passed away at age 31 in 1951.
The estate reached a settlement with Thermo Fisher in 2023.
Johns Hopkins broke ground on a Henrietta Lacks research building in 2024.
The estate settled with Novartis in February 2026.
The 16th annual memorial lecture is set for October 10, 2026.
Health Landscape
The Henrietta Lacks Memorial Lecture series serves as a focal point for institutional engagement regarding the history of HeLa cells. This latest disagreement illustrates the persistent complexity of balancing historical medical contributions with the rights and recognition of the estate.
The ongoing legal and social developments regarding the Henrietta Lacks estate emphasize the importance of informed consent in clinical research. Residents interested in the history of medical ethics may wish to track updates from the university regarding the transparency of future research programs.
The takeaway
The tension regarding the memorial lecture reflects the long-term impact of Henrietta Lacks on modern medicine. Patients and advocates should continue to monitor how research institutions navigate the ethical concerns of families whose loved ones' cells contributed to scientific progress.
Further reading
Learn more about the ongoing intersection of medical history and research ethics in the Cancer section.
Source note: This article includes information reported by TheGrio.
Live Poll
Should the families of deceased persons have veto power over events held in their name?
